Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 27, 2026
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.
Journal: Journal for immunotherapy of cancer
Published: April 15, 2026
Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma.
Journal: ESMO open
Published: October 29, 2025
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 10, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: July 16, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.
Journal: Cancer research communications
Published: June 25, 2025
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma.
Journal: ESMO open
Published: May 21, 2025
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 16, 2025
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 05, 2024
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 08, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 21, 2022
Last Updated: 09/26/2026